相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effect of molecular weights of microencapsulating polymers on viability of mouse-cloned pancreatic -cells: biomaterials, osmotic forces and potential applications in diabetes treatment
Armin Mooranian et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2018)
Electrokinetic potential-stabilization by bile acid-microencapsulating formulation of pancreatic beta-cells cultured in high ratio poly-L-ornithine-gel hydrogel colloidal dispersion: applications in cell-biomaterials, tissue engineering and biotechnological applications
Armin Mooranian et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects
Armin Mooranian et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
Influence of Biotechnological Processes, Speed of Formulation Flow and Cellular Concurrent Stream-Integration on Insulin Production from β-cells as a Result of Co-Encapsulation with a Highly Lipophilic Bile Acid
Armin Mooranian et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2018)
Long-Term Supplementation of Microencapsulated ursodeoxycholic Acid Prevents Hypertension in a Mouse Model of Insulin Resistance
H. Al-Salami et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2017)
New Biotechnological Microencapsulating Methodology Utilizing Individualized Gradient-Screened Jet Laminar Flow Techniques for Pancreatic β-Cell Delivery: Bile Acids Support Cell Energy-Generating Mechanisms
Armin Mooranian et al.
MOLECULAR PHARMACEUTICS (2017)
Innovative Microcapsules for Pancreatic β-Cells Harvested from Mature Double-Transgenic Mice: Cell Imaging, Viability, Induced Glucose-Stimulated Insulin Measurements and Proinflammatory Cytokines Analysis
Armin Mooranian et al.
PHARMACEUTICAL RESEARCH (2017)
Blood-Brain Barrier Dysfunction Precedes Cognitive Decline and Neurodegeneration in Diabetic Insulin Resistant Mouse Model: An Implication for Causal Link
Ryusuke Takechi et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Different insulin types and regimens for pregnant women with pre-existing diabetes
Sinead M. O'Neill et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Alginate-combined cholic acid increased insulin secretion of microencapsulated mouse cloned pancreatic β cells
Armin Mooranian et al.
THERAPEUTIC DELIVERY (2017)
A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes
Sangeetha Mathavan et al.
DRUG DELIVERY (2016)
Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: Formulation characterization and effects on production of insulin and inflammation in a pancreatic b-cell line
Armin Mooranian et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2016)
Designing anti-diabetic -cells microcapsules using polystyrenic sulfonate, polyallylamine, and a tertiary bile acid: Morphology, bioenergetics, and cytokine analysis
Armin Mooranian et al.
BIOTECHNOLOGY PROGRESS (2016)
The impact of allylamine-bile acid combinations on cell delivery microcapsules in diabetes
Armin Mooranian et al.
JOURNAL OF MICROENCAPSULATION (2016)
The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP/PKA pathway in pancreatic beta cells
Jean Franciesco Vettorazzi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The Influence of Stabilized Deconjugated Ursodeoxycholic Acid on Polymer-Hydrogel System of Transplantable NIT-1 Cells
Armin Mooranian et al.
PHARMACEUTICAL RESEARCH (2016)
Alginate-deoxycholic Acid Interaction and Its Impact on Pancreatic B-Cells and Insulin Secretion and Potential Treatment of Type 1 Diabetes
Armin Mooranian et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2016)
Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
Armin Mooranian et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment
Armin Mooranian et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2016)
Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cells
Armin Mooranian et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2016)
Primary Bile Acid Chenodeoxycholic Acid-Based Microcapsules to Examine β-cell Survival and the Inflammatory Response
Armin Mooranian et al.
BIONANOSCIENCE (2016)
Flow vibration-doubled concentric system coupled with low ratio amine to produce bile acid-macrocapsules of β-cells
Armin Mooranian et al.
THERAPEUTIC DELIVERY (2016)
A Gut Odyssey: The Impact of the Microbiota on Clostridium difficile Spore Formation and Germination
Aimee Shen
PLOS PATHOGENS (2015)
The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study
Armin Mooranian et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2015)
Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes
Armin Mooranian et al.
AAPS PHARMSCITECH (2015)
Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
Armin Mooranian et al.
JOURNAL OF MICROENCAPSULATION (2015)
An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
Armin Mooranian et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2015)
Starting bedtime glargine versus NPH insulin in poorly controlled type 2 diabetic patients with various hyperglycemia types (fasting type or postprandial type)
Markku A. Vahatalo et al.
ACTA DIABETOLOGICA (2014)
Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice
Benjamin L. Woolbright et al.
TOXICOLOGY LETTERS (2014)
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study
Armin Mooranian et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
Armin Mooranian et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
Armin Mooranian et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2014)
Inflammatory bowel disease: clinical aspects and treatments
Marc Fakhoury et al.
JOURNAL OF INFLAMMATION RESEARCH (2014)
Restoration of the Unfolded Protein Response in Pancreatic β Cells Protects Mice Against Type 1 Diabetes
Feyza Engin et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
Hani Al-Salami et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2012)
Glucose and Insulin Induction of Bile Acid Synthesis MECHANISMS AND IMPLICATION IN DIABETES AND OBESITY
Tiangang Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The bile acid sensor FXR regulates insulin transcription and secretion
Barbara Renga et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
Hani Al-Salami et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2009)
Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis
Ken Yasukawa et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2009)
Influence of the semisynthetic bile acid MKC on the ileal permeation of Gliclazide in vitro in healthy and diabetic rats treated with probiotics
H. Al-Salami et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2008)
Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3 alpha,7 alpha-dihydroxy-12-oxo-5 beta-cholanate, in healthy and diabetic rats
M. Mikov et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2007)
Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity
JH Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Evolution of the insulin molecule: insights into structure-activity and phylogenetic relationships
JM Conlon
PEPTIDES (2001)
Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects
C Einarsson et al.
HEPATOLOGY (2001)
When do environmental factors initiate islet cell damage in children with Type 1 diabetes mellitus?
GR Law et al.
DIABETIC MEDICINE (2000)
分享论文
